NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000012728

Registered date:30/12/2013

Effect on improvement of dyspeptic symptoms after the medication of esomeprazole

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedThe patient who has taken 10 mg of rabeprazole four weeks or more
Date of first enrollment2013/12/30
Target sample size100
Countries of recruitmentJapan
Study typeInterventional,observational
Intervention(s)esomeprazole 20mg

Outcome(s)

Primary OutcomeThe improvement rate of an upper abdomen symptom four or 6 weeks after medication of 20 mg esomeprazole.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaAllergy to esomeprazole

Related Information

Contact

public contact
Name Yoshinori FUJIMURA
Address 2-5-1, Nakai, Kita-ku, Okayama Japan
Telephone 086-225-7111
E-mail y.fujimura@me.com
Affiliation The Sakakibara Heart Institute of Okayama Gastroenterology
scientific contact
Name Yoshinori FUJIMURA
Address 2-5-1, Nakai, Kita-ku, Okayama Japan
Telephone 086-225-7111
E-mail y.fujimura@me.com
Affiliation The Sakakibara Heart Institute of Okayama Gastroenterology